DatasetName,MCRS1_S(269) MCRS1_S(282) MCRS1_S(291) MCRS1_S(72) MCRS1_S(95) MCRS1_T(90),MCRS1_S(108) MCRS1_S(121) MCRS1_S(20) MCRS1_S(21) MCRS1_S(22) MCRS1_S(27) MCRS1_S(295) MCRS1_S(7) MCRS1_S(85) MCRS1_S(87) MCRS1_S(89) MCRS1_S(9) MCRS1_S(90) MCRS1_S(99) MCRS1_T(103) MCRS1_T(116) MCRS1_T(5),MCRS1_S(115) MCRS1_S(35)
RM2024_Intensity D4-1___3,,,
RB2022_4_PostEndurance,0.6139428875662932,,
FSO2013_Ratio M/L normalized Rep3,,0.5033480968489799,
SR2019_MCF7_Biol_repl_3,,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,,
SR2019_LM2_Biol_repl_1,,,
RCJD2014_15min_1,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,
CK2022_7 16-1,0.6212629966718708,,
NJH2025_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_C,0.6097228265170543,0.5118223911962785,
RKK2015_TNF-α/basal,,,0.3360385111023919
JJ2018_Ratio H/M normalized pP2,,,
NJH2025_Sub12_MICT_Pre,,,
NJH2025_Sub7_MICT_Post,,,
DL2023_control-3,,,
ZX2022_Control Replicate 2,0.6261042808963939,,
HS2024_6_B_T3,,,
JW2015_Intensity pre1,,,
IMM2018_normalised rep. int. Empty-3,,,
AMK2021_30R_p5,,,
FSO2013_Ratio M/L normalized Rep1,,0.5304662505155359,
SR2019_MDAMB231_Biol_repl_4,,,
GF2025_P2_Sph,0.6205315508132901,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,,
NJH2025_Sub13_HIIT_Mid,,,
CP2009_Ratio M/L,,,
NJH2025_Sub7_HIIT_Post,,,
KBE2022_Log2_Ex_44_T,,,
DB2022_Intensity L2,,,
TM2022_mock.4h.C,,,
AST2020_anti-CD3.2,,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,,
HS2024_7_B_N1,,,
FSO2013_Ratio M/L normalized Rep1___1,,0.514229801980737,
SAS2015_AZD/DMSO_Exp3,,,
RM2024_Intensity D0-2___3,,,
RM2024_Intensity D6-1,,,
RB2022_8_RecoverySprint,,,
RB2022_5_PreEndurance,,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,,
EP2017_Untreated R#4 normalized log2 ratio,0.6344873160937854,0.5419211928434882,
WZ2023_Pu_010_30min,0.6226491523176376,0.5248699007610904,
AS2011_Ratio H/L Proteins RNAi_2,,,
RB2022_4_PreStrength,0.622490003267027,,
NJH2024_Sub4_MICT_Post,,,
AH2018_LFQ_M_1_X,0.6231074650723623,0.5021157960437284,
RB2022_8_RecoveryEndurance,,,
KBE2022_Log2_Ex_14_U,,,
FSO2013_Ratio M/L normalized Rep3___3,,,
AH2018_TMTMS3_1_C,0.6397776189638789,0.5240802652553613,
JJ2018_Ratio H/L normalized___1,,,
ZQ2022_C2,,,
RB2022_5_PreSprint,,,
PG2020_Intensity 8h_C,,,
AH2018_SILAC_MR_2_N,0.5990023701153478,0.5145658731527656,
MV2014_Ratio M/L normalized A1___2 (2 min),,,
TM2022_S2.8h.B,,,
MV2014_Ratio M/H normalized B3___1 (30 min),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,,
RM2024_Intensity D6-1___2,,,
NJH2025_Sub7_MICT_Mid,,,
LY2019_P1+,,0.5206160860597313,
AS2011_Ratio H/L Proteins Inhi_2,,,
BS2014_Log2(Ratio H/L normalized),,,
UK2020_HCM_2,,,
FSO2013_Ratio H/L normalized Rep2___2,,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5893605900747162,0.5242042049219033,
RM2024_Intensity D4-3___3,,,
RB2022_5_PreStrength,,,
NJH2024_Sub4_MICT_Mid,,,
TM2022_S2.4h.A,,,
RB2022_5_PostStrength,,,
GF2025_P6_Sph,0.6404248830560549,,
RB2022_2_PreSprint,,,
ZX2022_CB treated Replicate 3,0.6288453924384486,,
RM2024_Intensity D6-2___3,,,
WZ2023_Pe_025_10min,0.6159989866799741,0.5259664082374859,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,
AST2020_anti-CD3+PDL2.1,,,
KBE2022_Log2_Ex_34_U,,,
WZ2023_Pu_005_10min,0.6178635577984956,0.5233399918988988,
AS2011_Ratio H/L RNAi_2_1,,,
NJH2024_Sub9_HIIT_Mid,,,
CK2022_9 40-1,,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,,
LG2023_GSK3α-1_intensity,,,
WZ2023_Pu_025_30min,0.6193474931870919,0.5231102890109162,
AH2018_SILAC_MR_2_X,0.6016371640156787,0.5150457809443649,
HS2024_4_PD_T2,,,
NJH2024_Sub4_HIIT_Pre,,,
RB2022_2_RecoverySprint,,,
AS2011_Ratio H/L Protein RNAi_1,,,
RM2024_Intensity D2-1___2,,,
CR2017_Ratio Replicate 1.4,0.6039256798646498,0.5273775938171736,
FR2021_Norm.Intensity.B,,,
RM2024_Intensity D6-2___1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,
RB2022_5_PostSprint,,,
EJN2021_3_Rest_Basal,,,
CR2017_Ratio Replicate 1.3,,0.5177368738172268,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,
KTGR2014_Ratio-Rapa 7 mins,,,
AMK2021_120R_p1,,,
AH2018_SILAC_3_X,0.5817313476114933,,
JJ2018_Ratio M/L normalized pP3,,,
AH2018_SILAC_M_2_N,0.5812898619207241,0.5109323302664037,
HS2024_7_PD_T2,,,
FSO2013_Ratio H/L normalized Rep1___1,,0.5119859187687519,
AH2018_LFQ_1_C,0.6115690665932019,0.510152309715155,
AS2011_Ratio H/L Normalized Inhi_1_3,,,
KBE2022_Log2_Ex_28_T,,,
HS2024_3_B_N1,,,
RM2024_Intensity D4-2___3,,,
WZ2023_Pe_025_30min,0.6199347386444153,0.5270445688197388,
CK2022_11 40-1,,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,,
AH2018_SILAC_2_X,0.5860932262200703,,
MV2014_Ratio H/M normalized A2___2 (2 min),,,
AS2011_Ratio H/L RNAi_1_2,,,
KS2014_Intensity E15_1,0.6020057881319674,0.5136560704078447,
FSO2013_Ratio H/L normalized Rep2,,0.5164158540076697,
WZ2023_Pu_005_20min,0.6219878541395009,0.5241131518394428,
NJH2024_Sub10_MICT_Post,,,
RM2024_Intensity D2-3___1,,,
CR2017_Ratio Replicate 1.5,0.6065674317781111,0.5253057986269553,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,,
HS2024_7_B_T3,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,,
AS2011_Ratio H/L RNAi_1,,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,
AH2018_LFQ_M_1_C,0.615295806900602,0.5146049614972277,
NJH2025_Sub7_MICT_Pre,,,
SR2019_SKBR3_Biol_repl_2,,,
HS2024_9_B_T2,,,
KTGR2014_Ratio-AA 7 mins,,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,
HS2024_3_PD_T1,,,
FSO2013_Ratio M/L normalized Rep3___2,,0.4992432724190651,
SR2019_BT549_Biol_repl_3,,,
RCJD2014_20min_mean,,,
FR2021_Norm.Intensity.H,,,
RB2022_2_PreStrength,,,
DB2022_LFQ intensity L1.2,,,
HS2024_4_B_N1,,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,,
CK2022_1 16-1,0.6190134854408916,,
CK2022_1 200-1,0.6053953986673325,0.5140953940262376,
PG2020_Intensity Mock_10h_D,,,
SR2019_MCF10A_Biol_repl_2,,,
JJ2018_Ratio M/L normalized pP2___2,,,
HS2024_6_PD_T1,,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,,
RB2022_6_RecoveryEndurance,0.6078457533162153,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,,
EP2017_Mitotic R#2 normalized log2 ratio,0.59556435840237,0.517527736947774,
RCJD2014_5min_1,,,
RM2024_Intensity D4-1___1,,,
DL2023_24h-1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,,
TM2022_S2.4h.C,,,
SAS2015_PLX/AZD_Exp2,,,
CR2017_Ratio Replicate 3.3,0.6112216718361757,0.5280970176284345,
PG2020_Intensity 2h_C,,,
VOI2024_Veh2 di,,,
ZX2022_CB treated Replicate 2,0.6273535702118952,,
KBE2022_Log2_Ex_8_T,,,
NJH2025_Sub10_MICT_Post,,,
HS2024_6_I_T3,,,
RN2012_L11,,,
AS2011_Ratio H/L Normalized Inhi_2_2,,,
IMM2018_normalised rep. int. Empty-1,,,
HS2024_5_PD_T1,,,
AH2018_LFQ_M_2_C,0.6176556438199753,0.5195084981872695,
CK2022_3 40-1,,,
RBK2021_1260T Early,,,
NJH2024_Sub4_HIIT_Post,,,
HS2024_4_I_T1,,,
YA2020_Reporter_intensity_Cancer_No.5,0.6036423516886117,0.5190286469059362,
HH2022_Reporter intensity 8,,,
ZQ2022_N2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,,
FSO2013_Ratio H/L normalized Rep3___3,,,
AH2018_TMTMS3_2_N,0.6149913242568317,0.5095032664490311,
EJN2021_5_Rest_Basal,,,
NJH2025_Sub2_HIIT_Post,,,
NJH2025_Sub1_MICT_Post,,,
HS2024_9_B_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,
JAW2011_Ratio H/L LS2_1,,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,,
NJH2024_Sub6_HIIT_Pre,,,
AH2018_SILAC_3_N,0.5747489340939699,,
YA2020_Reporter_intensity_Normal_No.1,0.5999373012756634,0.5170245066623744,
HS2024_3_B_T1,,,
JJ2018_Ratio H/L normalized___2,,,
RM2024_Intensity D0-2,,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,
RB2022_7_PostStrength,0.6029044508559687,,
RB2022_1_PostEndurance,,,
CR2017_Ratio Replicate 3,0.6024800413233717,0.5301536443647733,
SR2019_Hs578T_Biol_repl_3,,,
MV2014_Ratio L/H normalized B3___1 (5 min),,,
RBK2021_1244T Early,,,
RB2022_3_PostSprint,,,
NJH2024_Sub13_MICT_Mid,,,
KTGR2014_Ratio-AA 2 mins,,,
GF2025_P7_Sph,0.6450122844021161,,
HS2024_8_I_T3,,,
CF2017_EOC 3,,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,,
HS2024_6_PD_T3,,,
DL2023_12h-2,,,
RM2024_Intensity D6-3___1,,,
FS2019_Ctr1,0.608453892642605,,
WZ2023_Pu_010_20min,0.6278962497987468,0.5233979961843954,
AS2011_Ratio H/L_3,,,
CK2022_1 40-1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,,
CK2022_8 16-1,0.6236352365175414,,
KS2014_Intensity N3,0.6085717218316429,0.5113719867085975,
RB2022_4_RecoveryEndurance,0.61184276028243,,
RB2022_5_RecoveryEndurance,,,
JAW2011_Ratio H/L LS1a_2,,,
NJH2024_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_N,0.6119009894693992,0.5034558495393873,
FSO2013_Ratio H/M normalized Rep2,,0.5021412274476318,
RAM2015_Log2 A,,0.5161195812508289,0.3841552856574614
HS2024_8_PD_T1,,,
JJ2018_Ratio H/L normalized pP2,,,
CF2017_OSE 27,,,
KS2014_Intensity E15_2,0.605365042260467,0.5208424339387857,
BS2014_Log2(Ratio H/L protein),,,
PG2020_Intensity 8h_A,,,
HS2024_7_I_T1,,,
VOI2024_Veh3 di,,,
RKK2015_TNF-α+SC-514/basal,,,0.42146944254549723
SR2019_JIMT1_Biol_repl_1,,,
HW2015_Ratio H/L normalized Exp2,,,
HS2024_3_I_N1,,,
AH2018_SILAC_M_3_X,0.583209715972041,0.5142981342595894,
NJH2024_Sub9_HIIT_Post,,,
AS2011_Ratio H/L RNAi_1_3,,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,
NJH2025_Sub1_HIIT_Pre,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,
NJH2024_Sub4_HIIT_Mid,,,
VOI2024_0.1uM 2 h_1 di,,,
KBE2022_Log2_Ex_6_T,,,
RM2024_Intensity D4-3___1,,,
AH2018_LFQ_4_X,0.6032036141325318,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
RB2022_8_PostEndurance,,,
NJH2025_Sub4_MICT_Mid,,,
YP2020_Intensity C30_R1_mult_log2,,,
AST2020_anti-CD3.1,,,
NJH2025_Sub4_HIIT_Post,,,
EP2017_Untreated R#4 log2 ratio,0.6333998795318728,0.5396845135176899,
HS2024_6_B_N1,,,
KBE2022_Log2_Ex_27_T,,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,,
VOI2024_0.1uM 24 h_1 mono,,,
AMK2021_120R_p5,,,
AS2011_Ratio H/L Proteins,,,
NJH2024_Sub7_HIIT_Post,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,,
AS2011_Ratio H/L RNAi_2_2,,,
RB2022_7_RecoveryStrength,0.6103464097867864,,
AH2018_SILAC_IT_3_X,0.5751823692385235,0.5204301343067028,
JAW2011_Ratio H/L,,,
PG2020_Intensity 10h_C,,,
FSO2013_Ratio M/L normalized Rep2,,0.509735242572367,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,
HH2022_Reporter intensity 5,,,
SR2019_HCC1954_Biol_repl_2,,,
CK2022_14 40-1,,,
RB2022_6_PreSprint,0.6183254670642965,,
NJH2025_Sub12_MICT_Mid,,,
PG2020_Intensity 4h_D,,,
NJH2025_Sub2_MICT_Post,,,
AH2018_LFQ_4_C,0.6057493979332845,0.49348469983421855,
DL2023_control-1,,0.5125893992745555,
AR2021_ALG 10 μM,,0.521137011993141,
JAW2011_Ratio H/L LS2_2,,,
AH2018_SILAC_IT_3_N,0.5715285997329606,0.5208674249547625,
EJN2021_4_Rest_Ins,,,
RN2012_H05,,,
NJH2024_Sub7_HIIT_Mid,,,
GF2025_P2_Adh,0.6138286150038823,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,,
RB2022_8_PostSprint,,,
EJN2021_1_Rest_Ins,,,
HH2022_Reporter intensity 3,,0.5200939567594277,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,,
AH2018_SILAC_IT_1_C,0.6070914782102711,0.51551304662013,
JW2021_After_3,,,
GF2025_P8_Sph,0.6332352735577443,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,,
JJ2018_Ratio M/L normalized pP2___1,,,
AH2018_SILAC_2_N,0.57957581708904,,
CK2022_11 200-1,0.6063005652643844,0.5203729848483548,
CK2022_12 200-1,0.602312204014877,0.5216068325702945,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,
RM2024_Intensity D2-1___3,,,
NJH2024_Sub1_MICT_Pre,,,
HH2022_Reporter intensity 9,,0.5146916362488414,
WZ2023_Su_010_20min,0.6192340818202356,0.5238619534380531,
AH2018_TMTMS2_2_N,0.6412125001232232,0.5264500796000654,
NJH2024_Sub13_MICT_Pre,,,
KBE2022_Log2_Ex_41_U,,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,,
AH2018_TMTMS3_Pool,0.6174096866160327,0.511684133031109,
KS2014_Intensity N4,0.6135886987532734,0.5042934632758886,
NJH2024_Sub1_HIIT_Post,,,
MM2018_Ratio H/L replicate2,,,
RM2024_Intensity D4-2___2,,,
NJH2024_Sub13_HIIT_Pre,,,
CF2017_OSE 26,,,
CK2022_14 200-1,0.6015373419713331,0.516556845300088,
SR2019_Hs578T_Biol_repl_1,,,
RB2022_7_PostSprint,0.5982189598561206,,
TM2022_mock.4h.A,,,
NJH2025_Sub12_HIIT_Pre,,,
AH2018_TMTMS3_1_N,0.6177629071362819,0.5083373202972697,
AST2020_anti-CD3+PDL2.2,,,
PG2020_Intensity Mock_10h_A,,,
JW2021_After_2,,,
NJH2024_Sub2_MICT_Post,,,
EJN2021_2_Rest_Ins,,,
SR2019_LM2_Biol_repl_4,,,
CP2009_Ratio H/M,,,
JAW2011_Ratio H/L HS,,,
CK2022_13 16-1,0.6110704324445725,,
GF2025_P1_Adh,0.5757198203744428,,
GF2025_P1_Sph,0.587395733959437,,
EJN2021_5_Ex_Basal,,,
HS2024_7_I_T3,,,
JJ2018_Ratio H/L normalized pP2___2,,,
WZ2023_Pe_010_10min,0.6169889497062376,0.5275698290927404,
CF2017_EOC 1,,,
CK2022_3 200-1,0.6062156161343045,0.5138005053434769,
AH2018_LFQ_IT_3_C,0.5798803285722945,,
SR2019_Hs578T_Biol_repl_2,,,
NJH2024_Sub12_HIIT_Post,,,
JJ2018_Ratio H/L normalized pP1___2,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,
NJH2024_Sub10_MICT_Mid,,,
NJH2024_Sub13_MICT_Post,,,
BS2014_Log2(Ratio H/L normalized Rep_1),,,
RB2022_3_RecoverySprint,,,
NJH2025_Sub1_HIIT_Mid,,,
RCJD2014_20min_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,,
HS2024_6_PD_T2,,,
HS2024_5_B_T1,,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,,
DL2023_12h-3,,0.5142231582904307,
SR2019_MDAMB231_Biol_repl_2,,,
HS2024_3_B_T2,,,
RB2022_6_PreStrength,0.6180159078503938,,
CK2022_2 40-1,,,
RB2022_1_PostSprint,,,
CK2022_4 200-1,0.6066958815785785,0.5138563311453567,
JW2021_Before_2,,,
TM2022_S2.12h.A,,,
MV2014_Ratio L/M normalized B2___2 (30 min),,,
CK2022_5 16-1,0.6207800665425077,,
AR2021_ALG 1 μM,,0.519284939876586,
HS2024_4_B_T1,,,
MV2014_Ratio M/H normalized A3___1 (10 min),,,
SR2019_BT549_Biol_repl_4,,,
EJN2021_1_Rest_Basal,,,
NJH2025_Sub8_MICT_Post,,,
RCJD2014_5min_3,,,
CR2017_Ratio Replicate 3.2,0.6096747257247254,0.5214761687732405,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,,
GF2025_P7_Adh,0.6165836170324498,,
CK2022_9 16-1,0.615327527642056,,
NJH2024_Sub6_HIIT_Post,,,
AMK2021_30R_p3,,,
AS2011_Ratio H/L Normalized RNAi_2,,,
RM2024_Intensity D0-2___2,,,
KS2014_Intensity pY_N4,,,
CK2022_13 200-1,0.6007850040626653,0.5165816352122752,
AS2011_Ratio H/L Normalized_2,,,
PG2020_Intensity 6h_D,,,
CK2022_16 16-1,0.6071096434517412,,
FS2019_db/db3,0.6044788666574428,0.5096758284427407,
CK2022_15 40-1,,,
NJH2024_Sub9_MICT_Pre,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,
WZ2023_Su_005_10min,0.6220341387977738,0.5249041383428695,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,,
KBE2022_Log2_Ex_41_T,,,
AMK2021_Ctrl_p1,,,
AH2018_LFQ_IT_3_X,0.5861189024589085,,
HS2024_5_PD_T3,,,
AH2018_TMTMS3_3_X,0.6171648674760352,0.512302643378857,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,,
KBE2022_Log2_Ex_40_U,,,
AH2018_LFQ_M_1_N,0.6110132448332667,,
KBE2022_Log2_Ex_27_U,,,
HW2015_Ratio M/L normalized Exp3,,,
RKK2015_TNF-α/IKKb(K44M),,,
AH2018_SILAC_M_1_N,0.6121794937963562,0.5080623294230502,
HW2015_Ratio M/L normalized Exp1,,,
RB2022_5_RecoveryStrength,,,
YP2020_Intensity P10_R1_mult_log2,,,
RB2022_7_PreStrength,0.6086310215093086,,
YA2020_Reporter_intensity_Normal_No.4,0.6164894060675427,0.5193109212675013,
NJH2025_Sub13_HIIT_Pre,,,
PG2020_Intensity CT_D,,,
NJH2025_Sub9_MICT_Post,,,
VOI2024_Veh1 mono,,,
CK2022_12 16-1,0.6045030797097172,,
RN2012_L13,,,
LG2023_Control-1_intensity,,,
RM2024_Intensity D6-3___2,,,
KBE2022_Log2_Ex_8_U,,,
SR2019_SKBR3_Biol_repl_3,,,
NJH2024_Sub1_MICT_Post,,,
HS2024_3_I_T2,,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,,
RM2024_Intensity D0-3___3,,,
HS2024_6_I_T2,,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,,
AS2011_Ratio H/L Protein Inhi_1,,,
FSO2013_Ratio H/M normalized Rep2___1,,0.5130739113339661,
GRW2016_Ratio M/L normalized SILAC 5a___2,,,
CK2022_10 40-1,,,
NJH2024_Sub12_HIIT_Pre,,,
NJH2024_Sub8_MICT_Pre,,,
RM2024_Intensity D0-1___1,,,
LY2019_P3+,,0.5246229973203358,
HH2022_Reporter intensity 6,,0.5135393507172251,
RB2022_2_RecoveryStrength,,,
KTGR2014_Ratio-AA 15 mins,,,
AS2011_Ratio H/L Normalized RNAi_2_2,,,
KS2014_Intensity pY_N3,,,
MV2014_Ratio H/L normalized B1___2 (30 min),,,
LY2019_P5-,,,
HW2015_Ratio M/L normalized Exp2,,,
SR2019_HCC1419_Biol_repl_1,,,
AH2018_TMTMS2_3_X,0.640159798390642,0.5251408336675898,
GF2025_P3_Adh,0.5780232620060587,,
SR2019_JIMT1_Biol_repl_2,,,
AH2018_TMTMS2_1_C,0.642192094125166,0.5278632191447412,
RM2024_Intensity D0-1___2,,,
LY2019_P4+,,0.5223169459995121,
KBE2022_Log2_Ex_19_U,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,,
RB2022_4_PostStrength,0.5939223332609277,,
LG2023_GSK3α-3_intensity,,,
YA2020_Reporter_intensity_Cancer_No.1,,0.519023378736665,
AST2020_Control,,,
JAW2011_Ratio H/L LS1a,,,
RCJD2014_5min_mean,,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,,
NJH2025_Sub1_MICT_Mid,,,
TM2022_S2.12h.C,,,
NJH2025_Sub9_MICT_Mid,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,,
AS2011_Ratio H/L Normalized Inhi_1_2,,,
FSO2013_Ratio M/L normalized Rep2___1,,0.5152513052222557,
LG2023_Control-2_intensity,,,
NJH2024_Sub8_HIIT_Pre,,,
KS2014_Intensity pY_N2,,,
RB2022_5_RecoverySprint,,,
RB2022_7_RecoverySprint,0.6222724770350807,,
YA2020_Reporter_intensity_Normal_No.3,0.6288021503268,0.5204138795566822,
HS2024_8_B_T2,,,
AH2018_LFQ_1_X,0.6194224404749447,,
RM2024_Intensity D6-1___1,,,
RCJD2014_10min_2,,,
FR2021_Norm.Intensity.M,,,
RM2024_Intensity D0-3___1,,,
KS2014_Intensity N2,0.6262993742102073,0.5022255353615013,
HH2022_Reporter intensity 1,,0.5198644256877,
HH2022_Reporter intensity 2,,0.5198186045216058,
RM2024_Intensity D6-2___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,,
RM2024_Intensity D2-3___2,,,
YA2020_Reporter_intensity_Normal_No.5,0.5991839942819109,0.5186357207323318,
SR2019_MCF7_Biol_repl_1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,,
HS2024_8_B_T1,,,
NJH2025_Sub6_HIIT_Pre,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,,
EP2017_Untreated R#2 log2 ratio,0.5771152375695953,0.5010832675827598,
SR2019_LM2_Biol_repl_3,,,
RB2022_4_RecoveryStrength,0.6080303480037731,,
CR2017_Ratio Replicate 2,0.607095539807927,0.509513769290728,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,,
FSO2013_Ratio H/M normalized Rep3,,0.4942535242708953,
AR2021_KD 72h,,0.5149179677542002,
MV2014_Ratio H/M normalized B2___3 (5 min),,,
KBE2022_Log2_Ex_18_U,,,
AS2011_Ratio H/L Inhi_1_1,,,
NJH2024_Sub8_MICT_Post,,,
AH2018_TMTMS3_3_C,0.6173750671576327,0.5096348690885114,
KBE2022_Log2_Ex_9_U,,,
AH2018_SILAC_M_3_N,0.5764316284275183,0.5166583725873969,
KBE2022_Log2_Ex_13_T,,,
RM2024_Intensity D0-3,,,
SR2019_SKBR3_Biol_repl_1,,,
PG2020_Intensity Mock_10h_C,,,
CF2017_OSE 29,,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,,
NJH2025_Sub1_HIIT_Post,,,
DL2023_24h-2,,,
HS2024_7_B_N2,,,
PG2020_Intensity 10h_A,,,
RN2012_L12,,,
MV2014_Ratio M/L normalized B1___3 (5 min),,,
NJH2024_Sub8_MICT_Mid,,,
AH2018_LFQ_IT_4_C,0.5788728018692365,,
SAS2015_PLX/AZD_Exp1,,,
FR2021_Norm.Intensity.A,,,
FSO2013_Ratio H/M normalized Rep1___1,,0.5144346144526182,
JW2015_Intensity cap2,,,
BS2014_Log2(Ratio H/L normalized Rep_2),,,
NJH2024_Sub6_MICT_Post,,,
CK2022_8 40-1,,,
RB2022_7_RecoveryEndurance,0.6101063242024304,,
NJH2025_Sub12_HIIT_Post,,,
EJN2021_4_Ex_Basal,,,
TM2022_S2.12h.B,,,
RN2012_L15,,,
KS2014_Intensity pY_PV3,,,
TM2022_S2.4h.B,,,
PG2020_Intensity 4h_A,,,
FSO2013_Ratio H/M normalized Rep2___2,,0.5085634662720738,
TM2022_mock.4h.B,,,
KBE2022_Log2_Ex_24_U,,,
NJH2025_Sub13_MICT_Mid,,,
KS2014_Intensity C3,0.6111749998317159,0.5168561953047647,
RB2022_1_PreSprint,,,
HS2024_4_I_N1,,,
CK2022_7 200-1,0.6131664063909815,0.5137926916407639,
CK2022_5 200-1,0.6097418691316902,0.5140489728704976,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,,
FSO2013_Ratio H/L normalized Rep2___1,,0.5164545180408104,
NJH2024_Sub10_HIIT_Mid,,,
RB2022_2_PostEndurance,,,
AH2018_LFQ_2_C,0.6137993476364986,0.5162687075903891,
AH2018_SILAC_MR_1_X,0.6203787809424074,0.5154465176071316,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,,
IMM2018_normalised rep. int. Empty-2,,,
RM2024_Intensity D4-1,,,
KBE2022_Log2_Ex_25_U,,,
AH2018_SILAC_3_C,0.5789456382219157,,
EJN2021_5_Rest_Ins,,,
VOI2024_0.1uM 24 h_3 di,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,,
DB2022_LFQ intensity L2.1,,,
FSO2013_Ratio H/M normalized Rep1,,0.5235032553665507,
CK2022_4 16-1,0.6200556444673659,,
AS2011_Ratio H/L,,,
SR2019_MCF7_Biol_repl_4,,,
EJN2021_2_Ex_Ins,,,
AS2011_Ratio H/L Inhi_2_3,,,
JAW2011_Ratio H/L LS1a_1,,,
AH2018_LFQ_1_N,0.6075005220699947,,
SAS2015_PLX/DMSO_Exp1,,,
SFR2015_HL_log2_ratio_avg_c,,,
JJ2018_Ratio M/L normalized pP2,,,
NJH2024_Sub7_MICT_Mid,,,
PG2020_Intensity 6h_B,,,
FSO2013_Ratio H/L normalized Rep3,,0.521032163958295,
GRW2016_Ratio H/L normalized SILAC 2___2,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,,
JJ2018_Ratio M/L normalized,,,
KTGR2014_Ratio-AA 30 mins,,,
JW2021_After_1,,,
NJH2025_Sub2_MICT_Mid,,,
HS2024_6_B_N2,,,
KBE2022_Log2_Ex_9_T,,,
AH2018_SILAC_IT_2_N,0.5788460539254875,0.5208348475109438,
AH2018_SILAC_IT_1_X,0.5752314554106763,0.520366408215831,
HW2015_Ratio H/L normalized Exp3,,,
HS2024_7_PD_T1,,,
UK2020_UA_2,,,
RM2024_Intensity D2-1___1,,,
GF2025_P10_Sph,0.6416872758466825,,
WZ2023_Pe_025_20min,0.6190608191307265,0.526103173183988,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,,
AH2018_LFQ_2_N,,0.49865780646050456,
HS2024_4_I_N2,,,
AH2018_TMTMS2_3_N,0.6381041406447409,0.5254780123258068,
RN2012_H06,,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
HS2024_4_PD_T3,,,
WZ2023_Su_005_30min,0.6214127803469444,0.5257044203552872,
SR2019_HCC1419_Biol_repl_4,,,
JJ2018_Ratio H/M normalized___2,,,
SR2019_JIMT1_Biol_repl_3,,,
AS2011_Ratio H/L Protein,,,
UK2020_HCM_3,,,
NJH2024_Sub10_HIIT_Post,,,
CR2017_Ratio Replicate 3.1,0.6179173656681409,0.5335322458449684,
WZ2023_Su_025_10min,0.6129322986282832,0.5249551236851443,
AH2018_LFQ_IT_4_X,0.5817634481324417,,
CP2009_Ratio H/L,,,
VOI2024_0.1uM 24 h_3 mono,,,
RB2022_4_RecoverySprint,0.6138456113348995,,
RM2024_Intensity D6-3,,,
WZ2023_Su_005_20min,0.6140738949693408,0.5257510257948144,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,,
SFR2015_HL_log2_ratio_avg_a,,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,,
RB2022_1_PreEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,,
LG2023_GSK3α-2_intensity,,,
EP2017_Pervanadate R#1 log2 ratio,0.6042438707659953,0.5317836265463507,
NJH2025_Sub6_HIIT_Post,,,
RB2022_6_RecoverySprint,0.6167002413981474,,
KS2014_Intensity,,0.5146343233025945,
MV2014_Ratio H/M normalized A2___1 (2 min),,,
PG2020_Intensity 8h_D,,,
LY2019_P7+,,,
EP2017_Untreated R#1 normalized log2 ratio,0.581076442783475,0.5142017248906469,
RN2012_L10,,,
PG2020_Intensity 4h_C,,,
EP2017_Mitotic R#3 normalized log2 ratio,0.5934433273227502,0.5155602792450166,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,,
DB2022_LFQ intensity L1,,,
KBE2022_Log2_Ex_24_T,,,
RB2022_8_PostStrength,,,
AH2018_SILAC_IT_2_X,0.5809037027459595,0.5203982521645583,
HS2024_4_B_T3,,,
NJH2024_Sub2_HIIT_Post,,,
HS2024_8_B_N2,,,
NJH2025_Sub8_HIIT_Pre,,,
JJ2018_Ratio H/L normalized pP2___1,,,
HS2024_8_I_T2,,,
KBE2022_Log2_Ex_6_U,,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,,
CR2017_Ratio Replicate 1.1,0.6105152320615566,0.5134542204137216,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,,
MV2014_Ratio M/H normalized B3___2 (30 min),,,
CK2022_16 200-1,0.6013107857455454,0.516032613449551,
VOI2024_0.1uM 2 h_3 di,,,
EP2017_Mitotic R#1 normalized log2 ratio,0.601361591967996,0.5184062407448276,
GF2025_P9_Sph,0.6517145663955816,,
CK2022_6 200-1,0.6141120908513442,0.5132834848534426,
NJH2024_Sub7_MICT_Post,,,
AH2018_TMTMS3_2_X,0.617731397821049,0.5144947958444357,
NJH2024_Sub8_HIIT_Post,,,
DB2022_LFQ intensity R1,,,
JW2015_Intensity cap3,,,
SR2019_HCC1954_Biol_repl_1,,,
HS2024_4_I_T2,,,
NJH2024_Sub2_MICT_Mid,,,
VOI2024_0.1uM 2 h_2 mono,,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,,
HS2024_4_PD_T1,,,
SAS2015_AZD/DMSO_Exp1,,,
NJH2024_Sub1_MICT_Mid,,,
IMM2018_normalised rep. int. CDK5L-3,,,
HS2024_3_B_T3,,,
MV2014_Ratio L/H normalized A3___2 (2 min),,,
NJH2025_Sub13_MICT_Pre,,,
SR2019_MDAMB231_Biol_repl_3,,,
GRW2016_Ratio H/L normalized SILAC 4___1,,,
MM2018_Ratio H/L replicate1,,,
PG2020_Intensity 2h_D,,,
EP2017_Untreated R#3 normalized log2 ratio,0.6212657787920164,0.5339588401895864,
MV2014_Ratio M/H normalized A3___3 (10 min),,,
NJH2024_Sub7_HIIT_Pre,,,
JAW2011_Ratio H/L LS2,,,
CK2022_8 200-1,0.6120273131852313,0.513808482046692,
KS2014_Intensity pY_C4,,,
CR2017_Ratio Replicate 3.5,0.6035112274250044,0.5256914960487474,
RB2022_7_PostEndurance,0.5983154513875427,,
NJH2025_Sub4_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,,
TM2022_mock.12h.A,,,
JJ2018_Ratio H/L normalized pP1,,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5809805532270621,0.516558851677467,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,,
KS2014_Intensity pY_E5_4,,,
RM2024_Intensity D4-3___2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,,
AH2018_SILAC_2_C,0.5797510596294694,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
HS2024_7_I_N1,,,
KBE2022_Log2_Ex_29_T,,,
HS2024_7_I_T2,,,
AS2011_Ratio H/L Normalized RNAi_2_3,,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,,
HS2024_6_B_T2,,,
AMK2021_45I_p5,,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,,
SAS2015_PLX/DMSO_Exp2,,,
EJN2021_1_Ex_Basal,,,
FR2021_Intensity.M,,,
RB2022_2_PostSprint,,,
AH2018_SILAC_MR_3_N,0.5989251920944797,0.5062673389381013,
MV2014_Ratio H/L normalized B1___3 (30 min),,,
CF2017_FTE 13,,,
PG2020_Intensity CT_C,,,
ZCP2016_Ratio H/L Rep 1,,,
FS2019_db/db2,0.6034323917761647,0.5159987825283705,
KS2014_Intensity pY_PV4,,,
KBE2022_Log2_Ex_39_U,,,
EP2017_Untreated R#3 log2 ratio,0.6197076367438924,0.5314477358402784,
RB2022_2_PostStrength,,,
AS2011_Ratio H/L Normalized_1,,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,
CR2017_Ratio Replicate 3.4,0.599220836150485,0.5176854897931618,
HS2024_8_PD_T2,,,
FS2019_Ctr2,,,
RB2022_6_PreEndurance,0.6085450731604236,,
FR2021_Norm.Intensity.G,,,
NJH2025_Sub9_HIIT_Post,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,,
RM2024_Intensity D4-3,,,
HS2024_8_B_N1,,,
NJH2025_Sub10_MICT_Mid,,,
KBE2022_Log2_Ex_15_U,,,
AS2011_Ratio H/L Normalized Inhi_2,,,
RKK2015_TNF-α/SC-514,,,0.4600540240520823
RB2022_3_PreSprint,,,
CR2017_Ratio Replicate 2.3,0.6139759296385868,0.5161070557122162,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,
GF2025_P4_Adh,0.5818182808141864,,
YA2020_Reporter_intensity_Normal_No.2,0.6021753575067462,0.5173717556921513,
YP2020_Intensity P30_R2_mult_log2,,,
NJH2025_Sub13_MICT_Post,,,
HS2024_4_B_N2,,,
HS2024_3_PD_T3,,,
AMK2021_120R_p3,,,
MV2014_Ratio L/H normalized A3___3 (2 min),,,
NJH2025_Sub10_HIIT_Pre,,,
FR2021_Intensity.G,,,
RAM2015_Log2 C,,0.5112390259824121,0.39306082078593585
AS2011_Ratio H/L Proteins Inhi_1,,,
FSO2013_Ratio H/M normalized Rep1___3,,,
AH2018_LFQ_M_2_N,,0.5061817599453651,
MV2014_Ratio M/L normalized A1___3 (2 min),,,
KBE2022_Log2_Ex_40_T,,,
CK2022_2 16-1,0.6180049658194587,,
RAM2015_Log2 B,,0.5152863863763661,
YP2020_Intensity C10_R1_mult_log2,,,
FSO2013_Ratio M/L normalized Rep1___2,,0.5345524735929349,
NJH2025_Sub8_MICT_Pre,,,
EJN2021_4_Rest_Basal,,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,,
JJ2018_Ratio H/M normalized pP3___1,,,
VOI2024_Veh2 mono,,,
HS2024_6_B_T1,,,
UK2020_HCM_5,,,
NJH2025_Sub10_HIIT_Post,,,
VOI2024_0.1uM 2 h_3 mono,,,
JW2015_Intensity pre3,,,
AS2011_Ratio H/L Normalized Inhi_2_1,,,
DL2023_24h-3,,,
HS2024_7_PD_T3,,,
PG2020_Intensity Mock_10h_B,,,
WZ2023_Su_025_30min,0.6231956569545156,0.5234726523412089,
AH2018_LFQ_4_N,0.6040378831328,0.5070820188718176,
CR2017_Ratio Replicate 1.2,,0.5191638341158649,
AS2011_Ratio H/L Normalized by Proteins,,,
RB2022_6_RecoveryStrength,0.6092445819974645,,
HS2024_8_I_N1,,,
AMK2021_Ctrl_p3,,,
AS2011_Ratio H/L Protein Inhi_2,,,
HH2022_Reporter intensity 7,,0.5115274615106226,
AH2018_SILAC_M_1_X,0.6127522037044112,0.49963678305867465,
RB2022_7_PreEndurance,0.6049862028686319,,
VOI2024_0.1uM 24 h_2 di,,,
DL2023_control-2,,0.5154908867408468,
LY2019_P6+,,,
DB2022_LFQ intensity R2,,,
GF2025_P6_Adh,0.6414956695211013,,
VOI2024_Veh1 di,,,
AS2011_Ratio H/L RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,,
VOI2024_Veh3 mono,,,
HS2024_5_I_T2,,,
NJH2025_Sub7_HIIT_Mid,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,,
RB2022_6_PostSprint,,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,,
AS2011_Ratio H/L Inhi_1,,,
AS2011_Ratio H/L Normalized RNAi_1_2,,,
AH2018_TMTMS3_2_C,0.617677000922734,0.5116351134041411,
SR2019_Hs578T_Biol_repl_4,,,
RB2022_8_PreStrength,,,
KS2014_Intensity C5,0.6029263776839294,0.5180001286064817,
RM2024_Intensity D0-1,,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,,
YP2020_Intensity P30_R1_mult_log2,,,
NJH2025_Sub2_HIIT_Pre,,,
RB2022_3_RecoveryEndurance,,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,,
GF2025_P9_Adh,0.6443188448294278,,
RB2022_3_PostStrength,,,
TM2022_S2.8h.A,,,
AS2011_Ratio H/L RNAi_1_1,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,
NJH2025_Sub2_MICT_Pre,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,
HS2024_4_B_T2,,,
SR2019_BT549_Biol_repl_1,,,
AH2018_LFQ_M_4_N,0.608422335503492,0.5109434297503749,
NJH2024_Sub8_HIIT_Mid,,,
PG2020_Intensity 8h_B,,,
AH2018_LFQ_2_X,0.6153566396123155,,
PG2020_Intensity 2h_B,,,
AS2011_Ratio H/L Proteins RNAi_1,,,
RB2022_4_PostSprint,0.6013853645881896,,
KS2014_Intensity E15_3,0.6045952206139046,0.5222572163967222,
GF2025_P3_Sph,0.5945047670857198,,
DB2022_LFQ intensity L2,,,
MV2014_Ratio H/L normalized A1___1 (10 min),,,
AH2018_SILAC_1_C,0.6097238942105251,0.5118382519050184,
NJH2024_Sub1_HIIT_Pre,,,
FSO2013_Ratio M/L normalized Rep2___2,,0.513176208242813,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,,
AS2011_Ratio H/L RNAi_2_3,,,
AH2018_SILAC_IT_1_N,0.5760381392626126,0.5208387999766306,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,,
RB2022_4_PreEndurance,0.6136143676826508,,
JJ2018_Ratio M/L normalized pP1,,,
CR2017_Ratio Replicate 2.4,0.6103421462052664,0.5139743368749966,
ZQ2022_N1,,,
LY2019_P6-,,,
RM2024_Intensity D2-3,,,
UK2020_HCM_1,,,
JW2015_Intensity pre2,,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,,
RM2024_Intensity D2-1,,,
NJH2025_Sub12_MICT_Post,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,
RN2012_L14,,,
AH2018_LFQ_3_N,0.6042250148132303,,
RKK2015_TNF-α/IKKb,,,
SFR2015_HL_log2_ratio_std_b,,,
UK2020_UA_1,,,
KBE2022_Log2_Ex_13_U,,,
AS2011_Ratio H/L Normalized Inhi_1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,,
RB2022_1_RecoverySprint,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,,
JJ2018_Ratio H/L normalized pP3,,,
CK2022_7 40-1,,,
AS2011_Ratio H/L Inhi_1_3,,,
NJH2025_Sub10_HIIT_Mid,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,,
JAW2011_Ratio H/L LS1b_1,,,
PG2020_Intensity 4h_B,,,
SR2019_BT549_Biol_repl_2,,,
RM2024_Intensity D4-2,,,
DB2022_LFQ intensity R2.2,,,
JJ2018_Ratio H/L normalized,,,
RB2022_5_PostEndurance,,,
HS2024_5_PD_T2,,,
WZ2023_Su_025_20min,0.6198891192409458,0.5246106956012752,
RM2024_Intensity D2-2___1,,,
IMM2018_normalised rep. int. CDK5L-2,,,
LY2019_P8-,,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,,
FSO2013_Ratio H/L normalized Rep1,,0.5110428125573032,
NJH2024_Sub2_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,,
CK2022_13 40-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,,
RN2012_H02,,,
PG2020_Intensity 10h_D,,,
RB2022_8_PreEndurance,,,
HS2024_3_B_N2,,,
EJN2021_4_Ex_Ins,,,
AS2011_Ratio H/L Normalized by Protein,,,
EJN2021_1_Ex_Ins,,,
EP2017_Pervanadate R#3 log2 ratio,0.5916905277002931,0.5271674282716323,
FSO2013_Ratio M/L normalized Rep1___3,,,
NJH2025_Sub4_HIIT_Mid,,,
RCJD2014_5min_2,,,
RB2022_6_PostStrength,0.6115425718774637,,
AH2018_SILAC_MR_3_C,0.6023268572185646,0.5115631594292867,
AH2018_LFQ_M_4_C,0.6102311059761266,0.506432889774837,
NJH2024_Sub4_MICT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_1_1,,,
DL2023_12h-1,,,
MV2014_Ratio L/M normalized B2___1 (30 min),,,
DB2022_LFQ intensity L1.1,,,
NJH2025_Sub6_MICT_Pre,,,
NJH2025_Sub6_MICT_Post,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,,
RN2012_H04,,,
CK2022_6 40-1,,,
DB2022_LFQ intensity R2.1,,,
KBE2022_Log2_Ex_42_U,,,
LY2019_P3-,,0.5124693667014594,
FR2021_Intensity.A,,,
EJN2021_3_Ex_Ins,,,
MV2014_Ratio M/L normalized A1___1 (2 min),,,
WZ2023_Pe_005_30min,0.6227556286030039,0.5262817312758101,
HS2024_8_PD_T3,,,
EJN2021_3_Ex_Basal,,,
AST2020_Control.1,,,
JW2015_Intensity cap1,,,
PG2020_Intensity CT_A,,,
FS2019_Ctr3,0.6087110702698323,,
WZ2023_Pu_025_20min,0.6280575792698123,0.5246902363904479,
NJH2025_Sub4_MICT_Post,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,,
GF2025_P10_Adh,0.6367678564044912,,
RB2022_1_RecoveryStrength,,,
SR2019_HCC1954_Biol_repl_4,,,
FR2021_Norm.Intensity.N,,,
HS2024_5_B_N1,,,
FSO2013_Ratio H/M normalized Rep3___3,,,
AH2018_TMTMS2_2_C,0.6404123165527255,0.5278673109878829,
RB2022_4_PreSprint,0.6110297731431593,,
DB2022_Intensity R2,,,
AH2018_TMTMS2_Pool,0.6175643423316717,0.508527673568554,
HS2024_8_I_N2,,,
RB2022_3_RecoveryStrength,,,
NJH2024_Sub6_HIIT_Mid,,,
AH2018_SILAC_M_1_C,0.6114890091932049,0.5149545318829245,
LY2019_P8+,,,
RB2022_2_RecoveryEndurance,,,
JJ2018_Ratio H/M normalized pP2___1,,,
JAW2011_Ratio H/L HS_1,,,
RB2022_3_PostEndurance,,,
KS2014_Intensity pY_PV1,,,
JAW2011_Ratio H/L LS1b_2,,,
SR2019_MCF7_Biol_repl_2,,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,,
AS2011_Ratio H/L Normalized RNAi_1_1,,,
AH2018_LFQ_M_4_X,0.6080692187133052,0.4960603430893514,
NJH2024_Sub6_MICT_Pre,,,
JJ2018_Ratio M/L normalized pP1___2,,,
YP2020_Intensity C30_R2_mult_log2,,,
NJH2024_Sub9_HIIT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_2_3,,,
RM2024_Intensity D0-1___3,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,,
KBE2022_Log2_Ex_28_U,,,
GRW2016_Ratio H/L normalized SILAC 1___1,,,
CF2017_FTE 17,,,
LY2019_P2-,,0.511740419924917,
AH2018_LFQ_IT_1_X,0.6122790398695926,0.4961294333199934,
JJ2018_Ratio H/L normalized pP3___1,,,
RB2022_8_RecoveryStrength,,,
WZ2023_Pe_005_20min,0.622077469762796,0.5271653797855916,
AST2020_Control.2,,,
NJH2025_Sub6_MICT_Mid,,,
RCJD2014_10min_1,,,
FSO2013_Ratio H/L normalized Rep2___3,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,,
HS2024_3_I_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,,
CK2022_4 40-1,,,
SR2019_MCF10A_Biol_repl_4,,,
KS2014_Intensity pY_C5,,,
NJH2025_Sub4_MICT_Pre,,,
NJH2024_Sub9_MICT_Post,,,
CF2017_OSE 28,,,
HS2024_5_B_T2,,,
HS2024_6_I_T1,,,
HS2024_5_B_T3,,,
JJ2018_Ratio H/M normalized pP1___1,,,
KBE2022_Log2_Ex_36_U,,,
AH2018_TMTMS3_3_N,0.6169618660113733,0.5068682028773741,
SR2019_HCC1419_Biol_repl_2,,,
FR2021_Intensity.N,,,
AS2011_Ratio H/L Inhi_2_1,,,
AH2018_SILAC_MR_1_C,0.6162385949359254,0.5133626558401854,
NJH2024_Sub1_HIIT_Mid,,,
NJH2025_Sub8_HIIT_Mid,,,
EP2017_Mitotic R#3 log2 ratio,0.5979232603978765,0.5217231677917068,
KBE2022_Log2_Ex_36_T,,,
NJH2025_Sub6_HIIT_Mid,,,
WZ2023_Pu_005_30min,0.6121932602506747,0.5235076241554877,
KS2014_Intensity C2,0.6117465319368977,0.5303705686124119,
FSO2013_Ratio H/L normalized Rep1___2,,,
RM2024_Intensity D2-2,,,
KBE2022_Log2_Ex_42_T,,,
CK2022_9 200-1,0.6052520283371138,0.5207304457166052,
GRW2016_Ratio H/L normalized SILAC 2___1,,,
JJ2018_Ratio H/M normalized pP3___2,,,
DB2022_LFQ intensity R1.1,,,
CK2022_10 200-1,0.6072259118432642,0.5202591225648633,
NJH2024_Sub9_MICT_Mid,,,
JAW2011_Ratio H/L_2,,,
HS2024_7_I_N2,,,
RBK2021_1332T Late,,,
LY2019_P1-,,0.5208190689670067,
RKK2015_TNF-α/basal.1,,,0.3780705589806126
RKK2015_TNF-α/TNF-α+SC-514,,,0.39978568892049327
CR2017_Ratio Replicate 2.5,0.6025128907638557,0.5235059918034266,
HS2024_3_I_T3,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,,
AS2011_Ratio H/L Normalized RNAi_1,,,
KS2014_Intensity E15_4,0.6007981531812876,0.5221241892439091,
ZQ2022_C3,,,
EJN2021_3_Rest_Ins,,,
YP2020_Intensity P10_R2_mult_log2,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,
NJH2025_Sub1_MICT_Pre,,,
KBE2022_Log2_Ex_39_T,,,
FSO2013_Ratio H/M normalized Rep3___2,,0.49066528042233204,
RM2024_Intensity D6-2,,,
EP2017_Untreated R#1 log2 ratio,0.5803187093783192,0.5119939236735446,
RKK2015_SC-514/basal,,,0.33623009372911417
RM2024_Intensity D6-1___3,,,
WZ2023_Pu_010_10min,0.6197207618223007,0.5245825326333053,
NJH2025_Sub9_HIIT_Mid,,,
SR2019_SKBR3_Biol_repl_4,,,
HS2024_5_I_T3,,,
KS2014_Intensity N1,0.6134321005814982,0.5088209060572018,
NJH2024_Sub12_MICT_Post,,,
TM2022_S2.8h.C,,,
CR2017_Ratio Replicate 1,0.600504284248332,0.5277009231834963,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,,
JJ2018_Ratio H/M normalized pP3,,,
AH2018_SILAC_MR_2_C,0.6223379392740651,0.5207252189998213,
LATM2013_Log2 Ratio (Medium/Light) Forward,,,
PG2020_Intensity 2h_A,,,
NJH2024_Sub6_MICT_Mid,,,
NJH2025_Sub13_HIIT_Post,,,
AH2018_SILAC_MR_3_X,0.5991214538064203,0.5101720326427824,
JJ2018_Ratio H/M normalized___1,,,
RCJD2014_15min_2,,,
AS2011_Ratio H/L_2,,,
AS2011_Ratio H/L Normalized,,,
RN2012_H03,,,
HS2024_5_B_N2,,,
HS2024_5_I_N1,,,
HS2024_6_I_N1,,,
AR2021_KD 48h,,0.5133089452671618,
FR2021_Intensity.B,,,
RB2022_3_PreEndurance,,,
HS2024_5_I_T1,,,
NJH2024_Sub10_MICT_Pre,,,
SR2019_LM2_Biol_repl_2,,,
AST2020_anti-CD3,,,
SR2019_MDAMB231_Biol_repl_1,,,
RM2024_Intensity D2-3___3,,,
WZ2023_Pe_005_10min,0.6201059095988312,0.526212451990097,
KBE2022_Log2_Ex_29_U,,,
HS2024_7_B_T1,,,
AH2018_LFQ_M_2_X,0.6195576209664112,,
AH2018_LFQ_IT_4_N,0.57473546841026,,
CK2022_15 200-1,0.6000131904929936,0.5165048786831692,
RM2024_Intensity D4-1___2,,,
JJ2018_Ratio H/M normalized,,,
JJ2018_Ratio M/L normalized pP3___1,,,
KBE2022_Log2_Ex_34_T,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,,
LY2019_P2+,,0.5063055361645652,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,,
CK2022_2 200-1,0.6027855508732768,0.5141366489076716,
AS2011_Ratio H/L Protein RNAi_2,,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,
WZ2023_Su_010_30min,0.6190063139334371,0.5245870688482229,
RN2012_H01,,,
KTGR2014_Ratio-Rapa 2 mins,,,
EJN2021_2_Rest_Basal,,,
KS2014_Intensity pY_E5_3,,,
MM2018_Ratio H/L replicate 3,,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.6025065866628774,0.5313079252687926,
HS2024_8_B_T3,,,
YA2020_Reporter_intensity_Cancer_No.3,0.6059743641905285,0.5191064497276966,
KBE2022_Log2_Ex_44_U,,,
WZ2023_Pe_010_20min,0.6229809835514466,0.525106734748835,
KS2014_Intensity pY_C6,,,
AS2011_Ratio H/L Normalized_3,,,
RCJD2014_15min_mean,,,
RB2022_3_PreStrength,,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,,
RCJD2014_10min_mean,,,
KS2014_Intensity C1,0.6137530856770076,0.5291269344685334,
FSO2013_Ratio H/M normalized Rep3___1,,0.5176580778373943,
AH2018_SILAC_M_3_C,0.5804372573618729,0.5211822430664829,
RKK2015_TNF-α+IKKb/TNF-α,,,
RM2024_Intensity D0-3___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,,
AH2018_SILAC_M_2_C,0.5812130319735656,0.5174521040247695,
AH2018_SILAC_M_2_X,0.5853569964157357,0.507558129133217,
KTGR2014_Ratio-Rapa 15 mins,,,
RM2024_Intensity D4-2___1,,,
KBE2022_Log2_Ex_15_T,,,
VOI2024_0.1uM 24 h_1 di,,,
WZ2023_Su_010_10min,0.6160542987358616,0.5241745949671149,
PG2020_Intensity 6h_C,,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,,
JJ2018_Ratio M/L normalized pP1___1,,,
AH2018_LFQ_M_3_N,0.6085311640073044,0.5100947185655272,
VOI2024_0.1uM 24 h_2 mono,,,
AH2018_TMTMS2_3_C,0.6406619471737406,0.5268612787459144,
CK2022_15 16-1,0.6097184030627106,,
CK2022_3 16-1,0.6206367755818764,,
LY2019_P4-,,0.5238414769273656,
FSO2013_Ratio H/L normalized Rep3___2,,,
KS2014_Intensity pY_PV2,,,
HS2024_3_I_N2,,,
GF2025_P8_Adh,0.6413049674231278,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,
GF2025_P5_Sph,0.5847138249014724,,
CK2022_10 16-1,0.6174215910604869,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,,
VOI2024_0.1uM 2 h_2 di,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,,
NJH2024_Sub2_HIIT_Mid,,,
AMK2021_45I_p3,,,
NJH2024_Sub13_HIIT_Mid,,,
DB2022_LFQ intensity R1.2,,,
DB2022_Intensity R1,,,
NJH2024_Sub12_MICT_Mid,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,,
UK2020_HCM_4,,,
SAS2015_AZD/DMSO_Exp2,,,
IMM2018_normalised rep. int. CDK5L-1,,,
DB2022_LFQ intensity L2.2,,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,,
EP2017_Mitotic R#1 log2 ratio,0.605067376127709,0.5136033082192814,
EJN2021_2_Ex_Basal,,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,,
KTGR2014_Ratio-Rapa 30 mins,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,,
CF2017_FTE 16,,,
AR2021_L41 10 μM,,0.5264603230528772,
CF2017_EOC 2,,,
RB2022_6_PostEndurance,0.5985993903265382,,
AH2018_SILAC_1_N,0.6118798496503073,0.5034586248585144,
NJH2024_Sub10_HIIT_Pre,,,
AS2011_Ratio H/L Inhi_1_2,,,
UK2020_HCM_6,,,
RB2022_7_PreSprint,0.6124528277331697,,
NJH2024_Sub2_MICT_Pre,,,
HS2024_3_PD_T2,,,
CK2022_6 16-1,0.6216071425381545,,
ZX2022_CB treated Replicate 1,0.6282556600017505,,
BS2014_Log2(Ratio H/L normalized Rep_3),,,
TM2022_mock.12h.C,,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,,
HH2022_Reporter intensity 0,,0.5202155245732528,
RM2024_Intensity D2-2___2,,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,
RB2022_1_PreStrength,,,
JJ2018_Ratio H/M normalized pP2___2,,,
AH2018_TMTMS2_2_X,0.6422314627944069,0.5258100555204501,
AR2021_L41 1 μM,,0.5162113384704381,
JJ2018_Ratio H/M normalized pP1___2,,,
AH2018_TMTMS2_1_N,0.6436071161804977,0.5254746479542357,
NJH2025_Sub10_MICT_Pre,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,,
ZX2022_Control Replicate 3,0.6269135656813072,,
KS2014_Intensity C4,0.6041421646352022,0.5223166957049414,
AS2011_Ratio H/L Inhi_2,,,
KBE2022_Log2_Ex_18_T,,,
NJH2025_Sub9_MICT_Pre,,,
RCJD2014_20min_1,,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,
FSO2013_Ratio M/L normalized Rep2___3,,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,
SR2019_MCF10A_Biol_repl_3,,,
HS2024_7_B_T2,,,
SAS2015_PLX/DMSO_Exp3,,,
AMK2021_Ctrl_p5,,,
NJH2025_Sub2_HIIT_Mid,,,
AH2018_LFQ_M_3_C,0.6200443006240417,0.5076659102066405,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,,
YA2020_Reporter_intensity_Cancer_No.2,0.58756668942269,0.5187763472536907,
FSO2013_Ratio H/M normalized Rep2___3,,,
RB2022_8_PreSprint,,,
AH2018_SILAC_IT_3_C,0.6132336151359284,0.5112387711889674,
WZ2023_Pu_025_10min,0.6196624559874179,0.5239057175707206,
RM2024_Intensity D2-2___3,,,
AS2011_Ratio H/L_1,,,
RCJD2014_10min_3,,,
FSO2013_Ratio M/L normalized Rep3___1,,0.5219273412498545,
SR2019_JIMT1_Biol_repl_4,,,
YP2020_Intensity C10_R2_mult_log2,,,
ZCP2016_Ratio H/L Rep 2,,,
CF2017_EOC 4,,,
JJ2018_Ratio H/L normalized pP1___1,,,
WZ2023_Pe_010_30min,0.6201365459974958,0.5255743310727975,
MV2014_Ratio L/M normalized B2___3 (30 min),,,
AH2018_LFQ_IT_3_N,0.5796169829850529,,
KS2014_Intensity C6,0.6146850429392559,0.5197125526498403,
ZQ2022_N3,,,
HW2015_Ratio H/L normalized Exp1,,,
CK2022_12 40-1,,,
NJH2024_Sub7_MICT_Pre,,,
ZX2022_Control Replicate 1,0.6306259942748869,,
JJ2018_Ratio H/M normalized pP1,,,
CK2022_16 40-1,,,
AH2018_SILAC_IT_2_C,0.6137475552557117,0.507813818911117,
CK2022_5 40-1,,,
AH2018_LFQ_3_X,0.6082177494304505,,
UK2020_UA_3,,,
LY2019_P7-,,,
GF2025_P5_Adh,0.585927116249734,,
RB2022_1_PostStrength,,,
JAW2011_Ratio H/L LS1b,,,
FSO2013_Ratio H/L normalized Rep3___1,,0.5210610440373794,
SR2019_HCC1954_Biol_repl_3,,,
CR2017_Ratio Replicate 2.2,0.607952638312642,0.5074165799429251,
VOI2024_0.1uM 2 h_1 mono,,,
MV2014_Ratio L/M normalized A2___1 (10 min),,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,,
CK2022_11 16-1,0.616251269533173,,
ZQ2022_C1,,,
CR2017_Ratio Replicate 2.1,0.6163237024656493,0.522308453138447,
PG2020_Intensity CT_B,,,
JJ2018_Ratio M/L normalized___2,,,
AH2018_SILAC_MR_1_N,0.5982605613646217,0.4988752244763188,
KS2014_Intensity pY_E5_1,,,
JW2021_Before_3,,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,,
MV2014_Ratio M/H normalized B3___3 (30 min),,,
FS2019_db/db1,0.6089259098207204,0.5187177820737365,
NJH2025_Sub9_HIIT_Pre,,,
JAW2011_Ratio H/L_1,,,
RCJD2014_20min_3,,,
AH2018_LFQ_3_C,0.616062309216645,0.5152224778920732,
JJ2018_Ratio M/L normalized pP3___2,,,
AMK2021_45I_p1,,,
NJH2025_Sub8_HIIT_Post,,,
AH2018_LFQ_M_3_X,0.6122371838233082,0.5098018738793049,
YA2020_Reporter_intensity_Cancer_No.4,0.6001627913820015,0.5184977649781687,
KS2014_Intensity pY_E5_2,,,
FSO2013_Ratio H/L normalized Rep1___3,,,
GF2025_P4_Sph,0.6151871730084166,,
RB2022_2_PreEndurance,,,
JW2021_Before_1,,,
KBE2022_Log2_Ex_25_T,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,
JJ2018_Ratio M/L normalized___1,,,
FR2021_Intensity.H,,,
CK2022_14 16-1,0.6093910045980643,,
AST2020_anti-CD3+PDL2,,,
MV2014_Ratio M/L normalized B1___1 (5 min),,,
KBE2022_Log2_Ex_19_T,,,
KS2014_Intensity pY_N1,,,
RB2022_1_RecoveryEndurance,,,
FSO2013_Ratio H/M normalized Rep1___2,,0.527845944222278,
HS2024_8_I_T1,,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,,
EP2017_Mitotic R#2 log2 ratio,0.5994806465381085,0.5226388922841793,
AH2018_TMTMS2_1_X,0.6425947100861448,0.5235831341610749,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,,
ZCP2016_Ratio H/L Rep 3,,,
AS2011_Ratio H/L Normalized RNAi_1_3,,,
SR2019_MCF10A_Biol_repl_1,,,
NJH2025_Sub8_MICT_Mid,,,
EJN2021_5_Ex_Ins,,,
HS2024_6_I_N2,,,
HH2022_Reporter intensity 4,,,
RBK2021_1326T Late,,,
TM2022_mock.12h.B,,,
NJH2024_Sub12_MICT_Pre,,,
RCJD2014_15min_3,,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,
LG2023_Control-3_intensity,,,
JJ2018_Ratio H/L normalized pP3___2,,,
CF2017_FTE 15,,,
HS2024_4_I_T3,,,
AH2018_SILAC_1_X,0.6122520346164331,0.49608240807680276,
PG2020_Intensity 10h_B,,,
AH2018_TMTMS3_1_X,0.6199182650790737,0.5135662077342711,
CF2017_FTE 14,,,
NJH2024_Sub13_HIIT_Post,,,
RM2024_Intensity D6-3___3,,,
NJH2025_Sub7_HIIT_Pre,,,
RBK2021_1259T Early,,,
RKK2015_IKK+TNF-α/IKKb,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,,
PG2020_Intensity 6h_A,,,
SR2019_HCC1419_Biol_repl_3,,,
KBE2022_Log2_Ex_14_T,,,
EP2017_Untreated R#2 normalized log2 ratio,0.5777490493535922,0.5025904116160625,
RM2024_Intensity D0-2___1,,,
DB2022_Intensity L1,,,
LY2019_P5+,,,
HS2024_5_I_N2,,,
SAS2015_PLX/AZD_Exp3,,,
EP2017_Pervanadate R#2 log2 ratio,0.5829017473932211,0.5196778846710047,
AS2011_Ratio H/L Normalized RNAi_2_1,,,
